Home » Topics » Coronavirus, BioWorld

Coronavirus, BioWorld
RSS

AVI Brings In $23M For Third-Generation Antisense Drugs

Nov. 16, 2005

Other News To Note

Nov. 3, 2005

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

New SARS Target Discoveries;Fresh Therapeutic Approaches

Sep. 19, 2005

By Anette Breindl

Analysts: Interest In Antisense Waning, But Science Not Dead

Sep. 16, 2005

Other News To Note

Sep. 13, 2005

Other News To Note

July 20, 2005

Found Coronavirus Might Have Ties To Pediatric Heart Disease

Feb. 11, 2005

By Anette Breindl

Driving A Spike Through Heart Of SARS Proving Challenging

Jan. 18, 2005

By Anette Breindl

Other News To Note

Dec. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...